Jean-Luc Faillie

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Topics

Health Insurance

Optical Coherence Tomography

Cross Sectional

Top Venues

Diabetes, obesity & metabolism

Fundamental & clinical pharmacology

PLoS neglected tropical diseases

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Sibylle de Germay, Elodie Pambrun, Antoine Pariente, Guillaume Grenet, Julien Bezin, Jean-Luc Faillie
Use of sodium-glucose cotransporter-2 inhibitors in France: Analysis of French nationwide health insurance database. Diabetes, obesity & metabolism 26 (5) (2024)
Sibylle de Germay, Elodie Pambrun, Antoine Pariente, Guillaume Grenet, Julien Bezin, Jean-Luc Faillie
Use of sodium-glucose cotransporter-2 inhibitors in France: Analysis of French nationwide health insurance database. Diabetes, obesity & metabolism (2024)
Sibylle de Germay, Elodie Pambrun, Antoine Pariente, Guillaume Grenet, Julien Bezin, Jean-Luc Faillie
Use of sodium-glucose cotransporter-2 inhibitors in France: Analysis of French nationwide health insurance database. Diabetes, obesity & metabolism 26 (5) (2024)
Sibylle de Germay, Elodie Pambrun, Antoine Pariente, Guillaume Grenet, Julien Bezin, Jean-Luc Faillie
Use of sodium-glucose cotransporter-2 inhibitors in France: Analysis of French nationwide health insurance database. Diabetes, obesity & metabolism 26 (5) (2024)
Cyrille Coustal, Juliette Vanoverschelde, Xavier Quantin, Candice Lesage, Jean-Marie Michot, Ariane Lappara, Stephane R Ederhy, Eric Assenat, Maxime Faure, Nahema Issa, Olivier Lambotte, Mathieu Puyade, Olivier Dereure, Diego Tosi, Patricia Rullier, Isabelle Serre, Romaric Larcher, Kada Klouche, Gérald Chanques, Hélène Vernhet-Kovacsik, Jean-Luc Faillie, Audrey Agullo, François Roubille, Philippe Guilpain, Alexandre Thibault Jacques Maria
Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series. Journal for immunotherapy of cancer 11 (5) (2023)
Marie Laure Laroche, Sophie Gautier, Elisabeth Polard, Marie-Blanche Rabier, Laurent Chouchana, Bénédicte Lebrun-Vignes, Jean-Luc Faillie, Nadine Petitpain, Laurence Lagarce, Annie-Pierre Jonville-Béra, null null
Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT). British journal of clinical pharmacology (2022)
Jérémy T Campillo, Michel Boussinesq, Sébastien Bertout, Jean-Luc Faillie, Cédric B Chesnais
Serious adverse reactions associated with ivermectin: A systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the World. PLoS neglected tropical diseases 15 (4) (2021)
Abdel Nasser Ado Moumouni, Perrine Robin, Dominique Hillaire-Buys, Jean-Luc Faillie
SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database. Fundamental & clinical pharmacology 32 (2) (2017)